1. Home
  2. SPRY vs NVTS Comparison

SPRY vs NVTS Comparison

Compare SPRY & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • NVTS
  • Stock Information
  • Founded
  • SPRY 2015
  • NVTS 2014
  • Country
  • SPRY United States
  • NVTS United States
  • Employees
  • SPRY N/A
  • NVTS N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • NVTS Semiconductors
  • Sector
  • SPRY Health Care
  • NVTS Technology
  • Exchange
  • SPRY Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • SPRY 1.1B
  • NVTS 1.3B
  • IPO Year
  • SPRY N/A
  • NVTS N/A
  • Fundamental
  • Price
  • SPRY $8.96
  • NVTS $13.46
  • Analyst Decision
  • SPRY Strong Buy
  • NVTS Buy
  • Analyst Count
  • SPRY 4
  • NVTS 7
  • Target Price
  • SPRY $31.25
  • NVTS $5.50
  • AVG Volume (30 Days)
  • SPRY 1.8M
  • NVTS 73.0M
  • Earning Date
  • SPRY 11-11-2025
  • NVTS 11-03-2025
  • Dividend Yield
  • SPRY N/A
  • NVTS N/A
  • EPS Growth
  • SPRY N/A
  • NVTS N/A
  • EPS
  • SPRY N/A
  • NVTS N/A
  • Revenue
  • SPRY $112,339,000.00
  • NVTS $68,167,000.00
  • Revenue This Year
  • SPRY N/A
  • NVTS N/A
  • Revenue Next Year
  • SPRY $193.13
  • NVTS $10.56
  • P/E Ratio
  • SPRY N/A
  • NVTS N/A
  • Revenue Growth
  • SPRY 22367.80
  • NVTS N/A
  • 52 Week Low
  • SPRY $8.45
  • NVTS $1.52
  • 52 Week High
  • SPRY $18.90
  • NVTS $17.79
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 36.31
  • NVTS 58.56
  • Support Level
  • SPRY $9.08
  • NVTS $12.38
  • Resistance Level
  • SPRY $10.38
  • NVTS $15.14
  • Average True Range (ATR)
  • SPRY 0.51
  • NVTS 1.77
  • MACD
  • SPRY -0.09
  • NVTS -0.25
  • Stochastic Oscillator
  • SPRY 17.43
  • NVTS 36.97

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: